CH Biotech R&D Co., Ltd. (TPE:6534)
Taiwan
· Delayed Price · Currency is TWD 93.40
-2.50 (-2.61%)
Apr 29, 2026, 1:30 PM CST
CH Biotech R&D Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 9,602 | 9,252 | 8,306 | 8,275 | 7,320 | 5,150 | Upgrade
|
| Market Cap Growth | 16.60% | 11.39% | 0.37% | 13.05% | 42.15% | 20.79% | Upgrade
|
| Enterprise Value | 9,869 | 9,704 | 8,439 | 8,371 | 7,556 | 5,884 | Upgrade
|
| Last Close Price | 93.40 | 85.86 | 73.40 | 70.18 | 61.91 | 42.71 | Upgrade
|
| PE Ratio | 20.76 | 19.94 | 17.44 | 17.86 | 15.73 | 17.67 | Upgrade
|
| PS Ratio | 5.28 | 5.09 | 5.08 | 5.46 | 5.10 | 5.06 | Upgrade
|
| PB Ratio | 3.57 | 3.45 | 3.14 | 3.28 | 3.51 | 2.99 | Upgrade
|
| P/TBV Ratio | 3.59 | 3.46 | 3.15 | 3.29 | 3.52 | 3.00 | Upgrade
|
| P/FCF Ratio | 20.62 | 19.87 | - | 15.17 | 12.51 | 26.76 | Upgrade
|
| P/OCF Ratio | 16.30 | 15.71 | 15.43 | 12.56 | 10.47 | 19.48 | Upgrade
|
| EV/Sales Ratio | 5.42 | 5.33 | 5.16 | 5.53 | 5.27 | 5.78 | Upgrade
|
| EV/EBITDA Ratio | 11.85 | 12.02 | 11.97 | 11.90 | 12.03 | 13.50 | Upgrade
|
| EV/EBIT Ratio | 15.92 | 15.57 | 15.56 | 14.79 | 14.78 | 16.38 | Upgrade
|
| EV/FCF Ratio | 21.19 | 20.84 | - | 15.35 | 12.91 | 30.58 | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.25 | 0.28 | 0.34 | 0.43 | 0.65 | Upgrade
|
| Debt / EBITDA Ratio | 0.79 | 0.79 | 1.02 | 1.16 | 1.38 | 2.47 | Upgrade
|
| Debt / FCF Ratio | 1.43 | 1.43 | - | 1.55 | 1.53 | 5.83 | Upgrade
|
| Net Debt / Equity Ratio | 0.10 | 0.10 | 0.10 | -0.04 | 0.17 | 0.46 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.33 | 0.33 | 0.38 | -0.14 | 0.58 | 1.83 | Upgrade
|
| Net Debt / FCF Ratio | 0.57 | 0.57 | -5.31 | -0.18 | 0.62 | 4.13 | Upgrade
|
| Asset Turnover | 0.51 | 0.51 | 0.45 | 0.44 | 0.46 | 0.35 | Upgrade
|
| Inventory Turnover | 2.12 | 2.12 | 2.25 | 1.72 | 1.98 | 2.04 | Upgrade
|
| Quick Ratio | 0.97 | 0.97 | 1.08 | 1.24 | 1.30 | 0.98 | Upgrade
|
| Current Ratio | 1.21 | 1.21 | 1.32 | 1.40 | 1.72 | 1.24 | Upgrade
|
| Return on Equity (ROE) | 17.39% | 17.39% | 18.41% | 20.11% | 24.43% | 18.20% | Upgrade
|
| Return on Assets (ROA) | 10.81% | 10.81% | 9.31% | 10.33% | 10.26% | 7.60% | Upgrade
|
| Return on Invested Capital (ROIC) | 16.86% | 17.32% | 16.31% | 18.59% | 16.92% | 11.72% | Upgrade
|
| Return on Capital Employed (ROCE) | 21.80% | 21.80% | 18.20% | 20.50% | 18.70% | 14.40% | Upgrade
|
| Earnings Yield | 4.83% | 5.01% | 5.73% | 5.60% | 6.36% | 5.66% | Upgrade
|
| FCF Yield | 4.85% | 5.03% | -0.60% | 6.59% | 7.99% | 3.74% | Upgrade
|
| Dividend Yield | 5.01% | 5.59% | 5.59% | 5.83% | 6.27% | 3.05% | Upgrade
|
| Payout Ratio | 90.84% | 90.84% | 77.47% | 102.26% | 27.21% | 14.48% | Upgrade
|
| Buyback Yield / Dilution | 0.05% | 0.05% | -5.50% | 0.77% | -0.54% | -0.44% | Upgrade
|
| Total Shareholder Return | 5.00% | 5.64% | 0.08% | 6.60% | 5.73% | 2.61% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.